Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ACSS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CCDC28B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PYGB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDH18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SKI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01133 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101929280 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF652 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAMKK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA1614 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WWC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GCNT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMED8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASH1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on